Hims & Hers Health (HIMS) Cash & Current Investments (2019 - 2026)
Hims & Hers Health (HIMS) posted Cash & Current Investments of $750.9 million for Q1 2026, up 30.02% sequentially from $577.5 million in Q4 2025, and up 132.71% YoY from $322.7 million in Q1 2025.
Hims & Hers Health (HIMS) Cash & Current Investments (2019 - 2026) Analysis & Trends
Hims & Hers Health has reported Cash & Current Investments for 8 years, with the latest figure at $750.9 million in Q1 2026.
- Quarterly Cash & Current Investments rose 132.71% year-over-year to $750.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $750.9 million (up 132.71% YoY) and the FY2025 annual result came in at $577.5 million, up 92.34% from the prior year.
- Cash & Current Investments improved to $750.9 million in Q1 2026 per HIMS's latest filing, from $577.5 million in the prior quarter.
- Over five years, Cash & Current Investments peaked at $1.1 billion in Q2 2025 and troughed at $179.6 million in Q4 2022.
- A 5-year average of $352.8 million and a median of $221.0 million in 2023 frame the typical range for Cash & Current Investments.
- The sharpest annual moves came in 2022 and 2025: Cash & Current Investments sank 38.56% in 2022, then surged 403.59% in 2025.
- Over 5 years, Cash & Current Investments stood at $179.6 million in 2022, then advanced by 23.02% to $221.0 million in 2023, then surged by 35.87% to $300.3 million in 2024, then soared by 92.34% to $577.5 million in 2025, then surged by 30.02% to $750.9 million in 2026.
- According to Business Quant data, Cash & Current Investments over the past three periods registered $750.9 million, $577.5 million, and $629.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | 963.33 Mn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 3.66 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 1.68 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 5.80 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 2.66 Bn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 886.50 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 389.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 530.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 164.00 Mn |
| 10 | Hims & Hers Health | 7.42 Bn | 6.57 Bn | 480.80 Mn | 841.05 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 841.05 Mn |
| Mar 31, 2026 | 750.88 Mn |
| Dec 31, 2025 | 577.49 Mn |
| Sep 30, 2025 | 629.74 Mn |
| Jun 30, 2025 | 1.14 Bn |
| Mar 31, 2025 | 322.67 Mn |
| Dec 31, 2024 | 300.25 Mn |
| Sep 30, 2024 | 254.07 Mn |
| Jun 30, 2024 | 227.29 Mn |
| Mar 31, 2024 | 203.59 Mn |
| Dec 31, 2023 | 220.98 Mn |
| Sep 30, 2023 | 212.50 Mn |
| Jun 30, 2023 | 193.14 Mn |
| Mar 31, 2023 | 184.39 Mn |
| Dec 31, 2022 | 179.63 Mn |
| Sep 30, 2022 | 198.39 Mn |
| Jun 30, 2022 | 194.98 Mn |
| Mar 31, 2022 | 203.05 Mn |
| Dec 31, 2021 | 247.27 Mn |
| Sep 30, 2021 | 252.43 Mn |